Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-05-13 / J Immunother Cancer 2014;2:10Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen /von 2014-05-13 / Cytotherapy 2014 Jul;16(7):946-64The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2014-05-07 / J Ovarian Res 2014 May;7:48Wilms‘ tumor gene 1 immunotherapy in pelvic gynecological malignancies
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Ovarian Cancer, Uterine Cancer /von 2014-05-02 / Expert Rev Clin Immunol 2014 Jun;10(6):705-11Immunotherapy for high-grade glioma
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-05-01 / Future Oncol 2014 May;10(6):911-5Adoptive cellular immunotherapy for the treatment of patients with breast cancer: a meta-analysis
/in Breast Cancer, Dendritic Cells, International Publications /von 2014-05-01 / Cytotherapy 2014 Jul;16(7):934-45Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2014-04-29 / Cancer Immunol. Immunother. 2014 Aug;63(8):797-806Colorectal cancer and immunity: what we know and perspectives
/in Dendritic Cells, International Publications /von 2014-04-14 / World J. Gastroenterol. 2014 Apr;20(14):3738-50SnapShot: cancer vaccines
/in Dendritic Cells, International Publications /von 2014-04-10 / Cell 2014 Apr;157(2):516-516.e1
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de